Lomitapide
Contents
Description
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including apheresis, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH). It is used to treat familial dysbetalipoproteinemia.
Indications & Therapeutic Use
Homozygous Familial Hypercholesterolemia, Familial Dysbetalipoproteinemia
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Lomitapide — GNH India
4 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Lomitapide products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Lomitapide |
| Brands | 1 brand available |
| Active Ingredient | Lomitapide |
| Drug Class | Homozygous Familial Hypercholesterolemia |
| Manufacturer | Aegerion Pharmaceuticals |
| Dosage Forms | Capsule |
| Medical Code | C10AX12 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 4 countries |